Collective Audience Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Collective Audience Inc (CAUD) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Collective Audience Inc vs Its Competitors
- Growth: Collective Audience Inc generated 2,866.9% revenue growth year over year in Q3 2024, vs 8.2% for its tracked competitors combined.
- Profitability: Its -337.9% net margin compares with -2.8% for the peer group.
- Peer revenue share: Collective Audience Inc accounted for 0.9% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CAUD Sales vs. its Competitors, Q3 2024
Collective Audience Inc reported revenue growth of 2,866.90 % year on year in Q3 2024, above its competitors' combined revenue growth of 8.16 %.
With a net margin of -337.86 %, Collective Audience Inc reported lower profitability than its competitors (-2.77 %).
Collective Audience Inc generated 0.94 % of the combined sales of its peer group, up from 0.03 % a year earlier.
Collective Audience Inc vs. its Competitors, Q3 2024
Revenue growth, year on year
Net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Collective Audience Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Collective Audience Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Collective Audience Inc's competitor groups requires a Commercial License.
For context: the Consulting Services industry grew revenue 7.1% year over year, combined, vs 2,866.9% for Collective Audience Inc. Collective Audience Inc's share of combined industry revenue moved from 0.00% to 0.02%, a gain of 0.01 percentage points.
Collective Audience Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Collective Audience Inc | - | - | - | Yes |
| Competitors combined (1) | ||||
| High-Confidence Competitors (6) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CAUD Stock Performance relative to its Competitors
CAUD Stock Performance relative to High-Confidence Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Clover Health Investments Corp | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Collective Audience Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Collective Audience Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Collective Audience Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Collective Audience Inc | 0.16 | - |
| Clover Health Investments Corp | 2,359.06 | 2,476.71 |
| SUBTOTAL | 2,359.22 | 2,476.71 |
Sources: Collective Audience Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Collective Audience Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Collective Audience Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| EverCommerce | Named by the company | 85% |
| Braze | Named by the company | 85% |
| Porch Group | Named by the company | 85% |
| Cardlytics | Named by the company | 85% |
| AdTheorent | Named by the company | 85% |
| Quinstreet | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Collective Audience Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Collective Audience Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Clover Health Investments Corp | Insurance 99.27 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Collective Audience Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Collective Audience Inc | 0 | - | - |
| Clover Health Investments Corp | 2,359 | 3,420,874 | -25,362 |
| PEERS TOTAL | 2,359 | 3,420,874 | -25,362 |
Collective Audience Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 34 companies in Collective Audience Inc's industry classification, broader than the peer set above. Market cap in millions of $.Collective Audience Inc ranks #0 of 34 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,720, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Cgi Inc | 14,393 | 32.07 % |
| 2 | Booz Allen Hamilton Holding Corporation | 8,395 | 18.71 % |
| 3 | Genpact Limited | 5,489 | 12.23 % |
| 4 | Fti Consulting Inc | 3,843 | 8.56 % |
| 5 | Exponent Inc | 1,234 | 5.2% |
| 6 | Huron Consulting Group Inc | 1,234 | 5.2% |
| 7 | Astrana Health Inc | 1,234 | 5.2% |
| 8 | Icf International Inc | 1,234 | 5.2% |
| 9 | Bowman Consulting Group Ltd | 1,234 | 5.2% |
| 10 | Onterris Inc | 1,234 | 5.2% |
| 0 | Collective Audience Inc | 0 | 0.00 % |
Market cap and industry share for the rest of Collective Audience Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Collective Audience Inc's Valuation vs Competitive Position
Valuation multiples vs the Consulting Services industry average (44 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Consulting Services industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 27.6x | - |
| EV / EBITDA | - | 10.7x | - |
| P/B | -2.2x | 2.4x | -4.6x |
| Return on Equity | 113,603.55 % | industry aggregate | 113,583.03 % |
| Return on Invested Capital | -149.63 % | 6.13 % (avg) | -155.76 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Collective Audience Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue Growth | - | - | - |
| Operating Margin | - | -295.30 % | - |
| Return on Invested Capital | - | -7.90 % | -195.31 % |
| P/E | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Collective Audience Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,720 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See Collective Audience Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Collective Audience Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Collective Audience Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Return on equity 113,583.0 points above the industry aggregate.
Weaknesses
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-46.5% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Collective Audience Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Collective Audience Inc | 0.02 | 0.27 | - |
| Clover Health Investments Corp | - | 1.36 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Collective Audience Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Collective Audience Inc | Q3 2024 | +2,866.9 % | - |
| Clover Health Investments Corp | Q2 2026 | +55.6 % | - |
| PEERS TOTAL | +56.2 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Collective Audience Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Collective Audience Inc | Q3 2024 | - | - |
| Clover Health Investments Corp | Q2 2026 | +27.9 % | +19.9 % |
Collective Audience Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Collective Audience Inc | - | - | - |
| Clover Health Investments Corp | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Collective Audience Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Collective Audience Inc | - | - |
| Clover Health Investments Corp | - | 0.95 |
| PEERS AVERAGE | - | 0.95 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.